CD69 and COVID-19: A significantly higher proportion of CD8+CD161+Vα7.2+ MAITs expressed proliferation marker Ki67 and activation marker CD69 in the acute samples indicating active proliferation and activation during acute COVID-19 as compared to convalescence (Fig. 1D, E).